Dr. Doucette, Dr. Dolinsky, and Dr. Hatch conducted a study to study the role of TAZ (Tafazzin), a cardiolipin (CL) biosynthetic enzyme important for maintaining mitochondrial function in regulating pancreatic islet function, particularly under low-glucose conditions.
CLICK HERE for the full article
What's New
All Articles
Now Recruiting Participants for a Research Study!
The Type 1 Diabetes Exercise and Mentorship (TEAM) Trial is recruiting teenagers living with type 1 diabetes in the Winnipeg…
3 DREAM Researchers Receive Funding from 2026 CHRIM Operating Grants
Congratulations to Drs. Ayesha Saleem, Sukhpreet Tamana, and Jennifer Yamamoto who received close to $150,000 in funding from the 2026…
iCARE Study Reached Their Recruitment Target!
Congratulations to the iCARE team on hitting their recruitment target of 375 participants in Manitoba! Huge thank you to the…
Check out the latest DREAM Newsletter!
The DREAM theme is excited to announce the release of our third newsletter! Here you will find updates from our…
Island Lake Anisininew Nations Annual General Assembly
The iCARE and Next Generation team was honoured to be invited to participate in the Island Lake Anisininew Nations Annual…
Can-SOLVE CKD’s 10th Annual Meeting
From May 7 – 9, 2026, Can-SOLVE CKD held their 10th Annual Meeting in Quebec City. Dr. Allison Dart received…